BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31660843)

  • 1. Evaluation of Tissue and Serum Expression Levels of Lactate Dehydrogenase Isoenzymes in Patients with Head and Neck Squamous Cell Carcinoma.
    Mohtasham N; Ayatollahi H; Saghravanian N; Zare R; Shakeri MT; Sahebkar A; Mohajertehran F
    Anticancer Agents Med Chem; 2019; 19(17):2072-2078. PubMed ID: 31660843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
    Bhattacharjee A; Giri S; Roy M; Chakraborty A
    J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase.
    Grimm M; Krimmel M; Hoefert S; Kraut W; Calgéer B; Biegner T; Teriete P; Munz A; Reinert S
    J Oral Pathol Med; 2016 May; 45(5):346-55. PubMed ID: 26403591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Lactate Dehydrogenase in the Saliva and Tissues of Patients with Head and Neck Squamous Cell Carcinoma.
    Mohajertehran F; Ayatollahi H; Jafarian AH; Khazaeni K; Soukhtanloo M; Shakeri MT; Mohtasham N
    Rep Biochem Mol Biol; 2019 Jan; 7(2):142-149. PubMed ID: 30805393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue.
    Ziebart T; Walenta S; Kunkel M; Reichert TE; Wagner W; Mueller-Klieser W
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):193-9. PubMed ID: 20383719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis.
    Zhang C; Qiao H; Guo W; Liu Y; Yang L; Liu Y; Jin B; Fu M; Wang G; Li W
    Cancer Lett; 2019 Jul; 455():1-13. PubMed ID: 30981760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis.
    Li YY; Jin F; Zhou JJ; Yu F; Duan XF; He XY; Wang R; Wu WL; Long JH; Luo XL
    Chronobiol Int; 2019 Dec; 36(12):1723-1732. PubMed ID: 31609143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ZCCHC6 expression in peripheral blood mononuclear cells by HNSCC secretions.
    Arayataweegool A; Srisuttee R; Bin-Alee F; Mahattanasakul P; Tangjaturonrasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
    Gene; 2020 Sep; 754():144880. PubMed ID: 32526260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer.
    Chen Y; Maniakas A; Tan L; Cui M; Le X; Niedzielski JS; Michel KA; Harlan CJ; Lu W; Henderson YC; Mohamed ASR; Lorenzi PL; Putluri N; Bankson JA; Sandulache VC; Lai SY
    Br J Cancer; 2021 May; 124(10):1670-1679. PubMed ID: 33742144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis of serum mRNA in patients with head and neck squamous cell carcinoma at whole-genome scale.
    Čapková M; Šáchová J; Strnad H; Kolář M; Hroudová M; Chovanec M; Čada Z; Šteffl M; Valach J; Kastner J; Vlček Č; Smetana K; Plzák J
    Biomed Res Int; 2014; 2014():408683. PubMed ID: 24864240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities in mRNA expression of peripheral blood drug metabolizing enzymes and cancer marker genes with biopsy samples of head and neck cancer patients.
    Hasan F; Katiyar T; Maurya SS; Yadav V; Yadav S; Pandey R; Mehrotra D; Hadi R; Singh S; Bhatt ML; Parmar D
    Biomarkers; 2019 Sep; 24(6):574-583. PubMed ID: 31002268
    [No Abstract]   [Full Text] [Related]  

  • 13. MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinoma.
    Ardalan Khales S; Ebrahimi E; Jahanzad E; Ardalan Khales S; Forghanifard MM
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e434-e441. PubMed ID: 29333702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma.
    Hanemaaijer SH; van Gijn SE; Oosting SF; Plaat BEC; Moek KL; Schuuring EM; van der Laan BFAM; Roodenburg JLN; van Vugt MATM; van der Vegt B; Fehrmann RSN
    Oral Oncol; 2018 May; 80():33-39. PubMed ID: 29706186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
    Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
    Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the response of human head and neck squamous cell carcinoma to irradiation in a microfluidic model allowing customized therapy.
    Cheah R; Srivastava R; Stafford ND; Beavis AW; Green V; Greenman J
    Int J Oncol; 2017 Oct; 51(4):1227-1238. PubMed ID: 28902347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.